vs

Side-by-side financial comparison of OPEN TEXT CORP (OTEX) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× OPEN TEXT CORP). ResMed runs the higher net margin — 27.6% vs 12.7%, a 14.9% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs -0.6%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs -4.3%).

Open Text Corporation is a global software company that develops and sells information management software.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

OTEX vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.1× larger
RMD
$1.4B
$1.3B
OTEX
Growing faster (revenue YoY)
RMD
RMD
+11.6% gap
RMD
11.0%
-0.6%
OTEX
Higher net margin
RMD
RMD
14.9% more per $
RMD
27.6%
12.7%
OTEX
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
-4.3%
OTEX

Income Statement — Q2 FY2026 vs Q4 FY2026

Metric
OTEX
OTEX
RMD
RMD
Revenue
$1.3B
$1.4B
Net Profit
$168.1M
$392.6M
Gross Margin
74.0%
61.8%
Operating Margin
22.0%
34.6%
Net Margin
12.7%
27.6%
Revenue YoY
-0.6%
11.0%
Net Profit YoY
-26.9%
13.9%
EPS (diluted)
$0.66
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OTEX
OTEX
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.3B
$1.4B
Q3 25
$1.3B
$1.3B
Q2 25
$1.3B
$1.3B
Q1 25
$1.3B
$1.3B
Q4 24
$1.3B
$1.3B
Q3 24
$1.3B
$1.2B
Q2 24
$1.4B
$1.2B
Net Profit
OTEX
OTEX
RMD
RMD
Q2 26
$392.6M
Q4 25
$168.1M
$392.6M
Q3 25
$146.6M
$348.5M
Q2 25
$28.8M
$379.7M
Q1 25
$92.8M
$365.0M
Q4 24
$229.9M
$344.6M
Q3 24
$84.4M
$311.4M
Q2 24
$248.2M
$292.2M
Gross Margin
OTEX
OTEX
RMD
RMD
Q2 26
61.8%
Q4 25
74.0%
61.8%
Q3 25
72.8%
61.5%
Q2 25
72.3%
60.8%
Q1 25
71.6%
59.3%
Q4 24
73.3%
58.6%
Q3 24
71.7%
58.6%
Q2 24
72.5%
58.5%
Operating Margin
OTEX
OTEX
RMD
RMD
Q2 26
34.6%
Q4 25
22.0%
34.6%
Q3 25
21.0%
33.4%
Q2 25
13.9%
33.7%
Q1 25
16.7%
33.0%
Q4 24
22.2%
32.5%
Q3 24
16.3%
31.6%
Q2 24
14.2%
31.2%
Net Margin
OTEX
OTEX
RMD
RMD
Q2 26
27.6%
Q4 25
12.7%
27.6%
Q3 25
11.4%
26.1%
Q2 25
2.2%
28.2%
Q1 25
7.4%
28.3%
Q4 24
17.2%
26.9%
Q3 24
6.6%
25.4%
Q2 24
18.2%
23.9%
EPS (diluted)
OTEX
OTEX
RMD
RMD
Q2 26
$2.68
Q4 25
$0.66
$2.68
Q3 25
$0.58
$2.37
Q2 25
$0.11
$2.58
Q1 25
$0.35
$2.48
Q4 24
$0.87
$2.34
Q3 24
$0.32
$2.11
Q2 24
$0.91
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OTEX
OTEX
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$1.3B
$1.4B
Total DebtLower is stronger
$6.4B
$663.8M
Stockholders' EquityBook value
$4.0B
$6.3B
Total Assets
$13.6B
$8.5B
Debt / EquityLower = less leverage
1.58×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OTEX
OTEX
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.3B
$1.4B
Q3 25
$1.1B
$1.4B
Q2 25
$1.2B
$1.2B
Q1 25
$1.3B
$932.7M
Q4 24
$1.1B
$521.9M
Q3 24
$1.0B
$426.4M
Q2 24
$1.3B
$238.4M
Total Debt
OTEX
OTEX
RMD
RMD
Q2 26
$663.8M
Q4 25
$6.4B
$403.9M
Q3 25
$6.4B
$408.7M
Q2 25
$6.4B
$658.4M
Q1 25
$6.4B
$663.1M
Q4 24
$6.4B
$662.9M
Q3 24
$6.4B
$667.6M
Q2 24
$6.4B
$697.3M
Stockholders' Equity
OTEX
OTEX
RMD
RMD
Q2 26
$6.3B
Q4 25
$4.0B
$6.3B
Q3 25
$4.0B
$6.1B
Q2 25
$3.9B
$6.0B
Q1 25
$4.1B
$5.5B
Q4 24
$4.2B
$5.3B
Q3 24
$4.1B
$5.2B
Q2 24
$4.2B
$4.9B
Total Assets
OTEX
OTEX
RMD
RMD
Q2 26
$8.5B
Q4 25
$13.6B
$8.5B
Q3 25
$13.5B
$8.3B
Q2 25
$13.8B
$8.2B
Q1 25
$13.8B
$7.6B
Q4 24
$13.7B
$7.1B
Q3 24
$13.8B
$7.2B
Q2 24
$14.2B
$6.9B
Debt / Equity
OTEX
OTEX
RMD
RMD
Q2 26
0.11×
Q4 25
1.58×
0.06×
Q3 25
1.61×
0.07×
Q2 25
1.62×
0.11×
Q1 25
1.55×
0.12×
Q4 24
1.51×
0.13×
Q3 24
1.55×
0.13×
Q2 24
1.52×
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OTEX
OTEX
RMD
RMD
Operating Cash FlowLast quarter
$318.7M
Free Cash FlowOCF − Capex
$279.4M
FCF MarginFCF / Revenue
21.1%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
1.90×
TTM Free Cash FlowTrailing 4 quarters
$878.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OTEX
OTEX
RMD
RMD
Q2 26
Q4 25
$318.7M
$339.7M
Q3 25
$147.8M
$457.3M
Q2 25
$158.2M
$538.8M
Q1 25
$402.2M
$578.7M
Q4 24
$348.0M
$308.6M
Q3 24
$-77.8M
$325.5M
Q2 24
$185.2M
$440.1M
Free Cash Flow
OTEX
OTEX
RMD
RMD
Q2 26
Q4 25
$279.4M
$311.2M
Q3 25
$101.2M
$414.4M
Q2 25
$124.0M
$508.2M
Q1 25
$373.8M
$557.9M
Q4 24
$306.7M
$288.0M
Q3 24
$-117.1M
$307.7M
Q2 24
$145.2M
$415.2M
FCF Margin
OTEX
OTEX
RMD
RMD
Q2 26
Q4 25
21.1%
21.9%
Q3 25
7.9%
31.0%
Q2 25
9.5%
37.7%
Q1 25
29.8%
43.2%
Q4 24
23.0%
22.5%
Q3 24
-9.2%
25.1%
Q2 24
10.7%
33.9%
Capex Intensity
OTEX
OTEX
RMD
RMD
Q2 26
Q4 25
3.0%
2.0%
Q3 25
3.6%
3.2%
Q2 25
2.6%
2.3%
Q1 25
2.3%
1.6%
Q4 24
3.1%
1.6%
Q3 24
3.1%
1.5%
Q2 24
2.9%
2.0%
Cash Conversion
OTEX
OTEX
RMD
RMD
Q2 26
Q4 25
1.90×
0.87×
Q3 25
1.01×
1.31×
Q2 25
5.49×
1.42×
Q1 25
4.33×
1.59×
Q4 24
1.51×
0.90×
Q3 24
-0.92×
1.05×
Q2 24
0.75×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OTEX
OTEX

Transferred At Point In Time$184.2M14%
Cybersecurity Enterprise Product$174.5M13%
Business Network Product$159.8M12%
Business Network Cloud Services And Subscriptions$151.4M11%
Content Cloud Services And Subscriptions$137.9M10%
Cybersecurity SMB Consumer Product$127.6M10%
Application Delivery Management Product$120.1M9%
IT Operations Management Product$113.3M9%
Professional Service And Other$82.5M6%
Analytics Product$58.1M4%
IT Operations Management Cloud Services And Subscriptions$7.8M1%

RMD
RMD

Segment breakdown not available.

Related Comparisons